A 2007 double-blind, multicenter trial (n=102) showed ALC 1,500 mg/day significantly improved tender point count, total myalgic score, depression, and musculoskeletal pain compared to placebo.[9] A 2015 RCT found ALC 1,500 mg/day comparable to duloxetine 60 mg/day for pain and depression.[8] Most notably, a 2023 RCT demonstrated that adding PEA 1,200 mg/day + ALC 2,000 mg/day to ongoing duloxetine + pregabalin therapy produced significantly greater improvements in Widespread Pain Index, FIQR, and FASmod scores.[7] Role in Treatment: ALC can be used as monotherapy or adjunctive therapy in fibromyalgia
Collectively, these developments underscore the paramount contribution of nanotechnology to redox-based oncological diagnostics and therapeutics and promising avenues towards more efficient and personalized cancer therapy [111]
International Classification of Diseases, 10th Revision (ICD-10)
Cinnamon, chocolate, tomatoes, and citrus all contain cinnamaldehyde and have been reported to cause rosacea flares
In a different reaction, 1 O 2 is produced by oxidation of H 2 O 2 and HOCl, catalysed by myeloperoxidase (MPO) enzyme while CYP 2E1 from ER and cytochrome c from mitochondria contribute to the formation of 1 O 2 atoms